Articles tagged with “mantle-cell-lymphoma”

Tecartus FDA Approval: ZUMA-2 Data for Mantle Cell Lymphoma

Review the FDA full approval of Tecartus for relapsed mantle cell lymphoma. This analysis covers ZUMA-2 Cohort 3 efficacy data, CAR-T safety, and clinical use.

25 min read

4/26/2026

tecartus fda approval mantle cell lymphoma car-t therapy zuma-2 trial kte-x19 clinical oncology btk inhibitors